DP Rejects Request to Withdraw Rank-and-File Prosecutors as National Assembly Investigation Witnesses: "Already Minimized"

"Uncovering Systematic Fabrication Is the Goal"
Reaffirms Commitment to Summoning High-Level Officials

On April 17, Sungjun Park, a member of the Democratic Party of Korea, commented on the request by Koo Jahyeon, Acting Prosecutor General, to withdraw the selection of rank-and-file prosecutors as witnesses for the National Assembly investigation. He stated, "In previous agency reports and hearings, the summoning of rank-and-file prosecutors or investigators as witnesses, except for those directly involved in fabrication cases, has been minimized."

Assemblyman Park is serving as the Democratic Party’s secretary on the National Assembly Special Investigation Committee for Fact-Finding on Political Prosecutorial Fabrication Charges under the Yoon Suk Yeol administration.

Sungjun Park, Democratic Party of Korea lawmaker. Photo by Yonhap News Agency

In a press briefing on April 17, Assemblyman Park said, "This National Assembly investigation is not about individual misconduct, but about uncovering the truth behind the prosecution's systematically orchestrated fabrication of investigations." He added, "Summoning witnesses at the level of those who planned and directed the investigation at that time is necessary for uncovering the truth and ensuring the public's right to know."

Regarding the suicide attempt by a prosecutor who had been selected as a witness, Assemblyman Park stated, "I would like to express my deepest condolences at this unfortunate news," and added, "I wish for a speedy recovery."

On his way home from the Supreme Prosecutors’ Office in Seocho District earlier that day, Acting Prosecutor General Koo said, "For future National Assembly investigations, I ask that the selection of rank-and-file prosecutors or investigators as witnesses be withdrawn." He also requested, "If summoning is deemed necessary, please proceed in a careful and restrained manner, taking into account any potential impact on ongoing trials."

This content was produced with the assistance of AI translation services.